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hERG Subunit-Specific Contributions to Gating and Disease
Gail A. Robertson, Ph.D.
Dept. of Physiology, University of Wisconsin-Madison, Madison, WI, USA.
From the identification of leg-shaking Drosophila mutants to the development
of drug safety tests and therapeutic treatments for cancer, the Ether-a`-go-go
family of ion channels has emerged as a rich collection of important targets
for translational research - applications of basic science to problems affecting
the human population. Critical to these developments has been the biophysical
characterization of channel behavior as it relates to their physiological and
pathological roles. We have focused on hERG subunits as components of the
repolarizing current cardiac IKr, which is a target for inherited and acquired
long QT syndrome (LQTS). In association with the originally-identified
hERG 1a isoform, hERG 1b modifies channel gating kinetics, increases current
amplitude and alters pharmacological sensitivity to a range of drugs. Computa-
tional models and the identification of a LQTS patient with a 1b-specific mu-
tation support a role for 1b in normal repolarization, a conclusion bolstered
by new findings of 1b abundance in human donor ventricle. These and other
findings regarding the composition and macromolecular context of channels
producing cardiac IKr will be discussed.
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Role of the N-Terminal PAS Domain of hERG K Channels in Gating,
Disease and Rescue
Matt Trudeau.
Univ of Maryland, Baltimore, MD, USA.
Human ERG (Kv11 or KCNH2) channels are voltage-activated K channels in
the eag family of channels. hERG is similar to other eag family member as they
are homologous to voltage- activated K channels but also share homology with
cyclic nucleotide-gated (CNG) channels. hERG shares important structural fea-
tures with other members of the eag family including an N-terminal PAS do-
main (Per-Arnt-Sim) and C-terminal cyclic nucleotide-binding homology
domain that is similar to the CNB domain of CNG, however eag family chan-
nels are not regulated by cyclic nucleotide. We have recently shown several
new properties for the hERG PAS domain and CNBHD. Recently, we showed
that the PAS domain made a direct interaction with the rest of the channel and
markedly regulated slow deactivation, which is a characteristic of wild-type
hERG. The CNBHD also plays a role in deactivation gating; it is necessary
for regulation of deactivation as channels with the CNBHD deleted lost slow
deactivation. Biochemical pull-down interactions and electrophysiology exper-
iments suggest that the PAS domain makes a direct interaction with the
CNBHD and that this interaction underlies slow deactivation. Mutations in
hERG-PAS that are linked to LQTS disrupt the interaction of the PAS domain
with the rest of the channel, indicating that disruption of this interaction may be
the mechanism behind some instances of LQTS. The PAS domain itself can be
used to fix aberrant gating in channels with PAS domain mutations, as if the
recombinant PAS domain substitutes for the covalently attached, but mutated
PAS domain. Here we will also discuss new data regarding the regulatory effect
of the PAS domain on other gating transitions besides deactivation and the role
of the region that connects the PAS domain to the transmembrane domain of the
channel.
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Cytoplasmic Domains of EAG Channels
Joao Morais-Cabral.
IBMC, Porto, Portugal.
The EAG channels (or more correctly, KCNH channels) are voltage-gated
potassium channels that play important roles in cardiac repolarization, neu-
ronal excitability, cellular proliferation and tumor growth. These channels
are tetrameric potassium channels with 6 trans-membrane (TM) helices per
subunit and characteristic large N- and C-terminal cytoplasmic regions.
The function of the cytoplasmic regions remains unclear; it is thought that
they are involved in channel regulation since they can be phosphorylated
and can interact with kinases, integrins and calmodulin. Interestingly, these
cytoplasmic regions contain well defined structural domains, a PAS (Per-
Arnt-Sim) domain in the N-terminus and a CNB (cyclic nucleotide binding)
homology domain in the C-terminus. The exact role of these domains is still
unknown but recent structural and functional data is revealing interesting
features.1071-Symp
EAG1: A Potassium Channel Involved in Cancer
Walter Stuhmer.
Max Planck Institute for Experimental Medicine, Gottingen, Germany.
There is increasing evidence for the causal involvement of ion channels in
cancer. Being extracellularly accessible, they constitute a novel and promising
targets to treat cancer. Kv10.1 is among the best-characterized ion channels im-
plicated in cancer. Kv10.1 is practically not detected in normal tissues outside
the central nervous system, but is aberrantly expressed with very high fre-
quency (>70%) in tumor cells from diverse origin. Its potential to favor tumor
progression is maintained to a large extent even if it is unable to permeate ions.
We have therefore searched for other mechanisms that mediate and/or favor its
malignancy and found that: a) siRNA against Kv10.1, inhibition of channel gat-
ing by astemizol and imipramine (both unspecific Kv10.1 blockers) or by
a monoclonal blocking antibody are all able to reduce proliferation rates in
cell lines expressing the channel. b) Kv10.1 has a high turnover rate at the
membrane and is rapidly ubiquitinated and degraded. c) it’s expression greatly
increases the secretion of VEGF under hypoxia, favoring angiogenesis in a
manner similar to the Hypoxia Inducible Factor (HIF). d) Kv10.1 can be de-
tected in the inner nuclear membrane and even potassium currents can be re-
corded from these membranes, indicating that it is functional. e) miRNA 34
regulates Kv10.1 and p53 in a reciprocal manner.
In retrospective studies it could be shown that Kv10.1 expression in hemaoto-
petic cells correlates with poor prognosis in a specific leukemia (AML M4).
Linking a Fab-fragment specific against Kv10.1 to TNF-related apoptosis
inducing ligand (TRAIL), it was possible to selectively induce apoptosis in can-
cer cells expressing Kv10.1 by an autocrine, and adjacent non-Kv10.1 bearing
cells by a paracrine mechanism.Symposium: Cargo Transport by Coupled
Molecular Motors
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On the Cooperativity of Microtubule Motors during Cargo Transport and
Directional Filament Sliding
Stefan Diez1,2.
1MPI-CBG, Dresden, Germany, 2B CUBE, Technische Universita¨t,
Dresden, Germany.
The stepping behavior of single microtubule-based motor proteins has been
studied in great detail. However, in cells, these motors often do not work alone
but rather function in groups when they transport cellular cargo or slide micro-
tubules against each other. Until now, the cooperative interactions between
motors in such groups are poorly understood. We will report on in vitro exper-
iments specifically designed to study the activity of coupled motors. With re-
spect to cargo transport by rigidly-coupled kinesin-1 motors, we investigated
(i) the step-size distribution of small groups of motors, (ii) the motility behavior
in the presence of obstacles, and (iii) the tug-of-war between antagonistically
acting force generators. With respect to the activity of diffusively-coupled ki-
nesin-14 motors during cell division, we studied (i) the directional sliding of
microtubules, (ii) the adaptive braking by passive crosslinkers, and (iii) the gen-
eration of torsional motion. All observed behaviors result from the collabora-
tive action of multiple motors - none of the described properties is found in
the activity of single motors.
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Collective Dynamics of Multiple Microtubule Motors: Connecting In Vitro
Observations to In Vivo Functions
Michael R. Diehl.
Bioengineering, Rice University, Houston, TX, USA.
Despite the efficiencies of many microtubule motors, sub-cellular cargos are
often transported by motor teams composed of multiple processive molecular
motors. Furthermore, mutant motors associated with diseases can be coupled
to cargos that are also outfitted with copies of wild-type motors. Together, these
observations raise important questions regarding the role of motor cooperation
in intracellular transport. Although abilities to characterize the transport behav-
iors of multiple motor systems have improved substantially, many aspects of
multiple-motor dynamics remain poorly understood. Here, I will describe our
efforts to create structurally-defined complexes composed of multiple kinesin
motors and examine their dynamics at the ‘single-motor’ level. I will also de-
scribe a transition rate model that predicts the load-dependent transport behav-
iors of these complexes from detailed measurements of a single motor’s elastic
